Tekturna HCT

Type: Product
Name: Tekturna HCT
First reported Jun 06 2014 - Updated Jun 06 2014 - 1 reports

GBI Research report shows key patent expiries to lead global anti-hypertensive market through fluctuating growth period by 2020

Multiple major drug patent expiries will cause the global anti-hypertensive market value to decline from $40 billion in 2013 to $37.6 billion by 2020, at a negative Compound Annual Growth Rate (CAGR) of 0.9 per cent says business intelligence provider ... [Published PharmaBiz - Jun 06 2014]
First reported Jun 03 2014 - Updated Jun 03 2014 - 1 reports

New Release on Breast Cancer Therapeutics in Major Developed Markets to 2020 by Researchmoz.us

ResearchMoz.us include new market research report "Breast Cancer Therapeutics in Major Developed Markets to 2020 - Approval of Novel Therapies to Support Continued Dominance of HER2 Targeted Drugs" to its huge collection of research reports. "Breast Cancer ... [Published PRWeb - Jun 03 2014]

Quotes

ResearchMoz.us include new marketmarket research report "Breast Cancer Therapeutics in Major Developed Markets to 2020 - Approval of Novel Therapies to Support Continued Dominance of HER2 Targeted Drugs" to its huge collection of research reports...

More Content

All (2) | News (2) | Reports (0) | Blogs (0) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
GBI Research report shows key patent expiries t... [Published PharmaBiz - Jun 06 2014]
New Release on Breast Cancer Therapeutics in Ma... [Published PRWeb - Jun 03 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.